A detailed history of Gamble Jones Investment Counsel transactions in Johnson & Johnson stock. As of the latest transaction made, Gamble Jones Investment Counsel holds 134,934 shares of JNJ stock, worth $21.1 Million. This represents 1.8% of its overall portfolio holdings.

Number of Shares
134,934
Previous 135,968 0.76%
Holding current value
$21.1 Million
Previous $22.2 Million 7.31%
% of portfolio
1.8%
Previous 1.81%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023

SELL
$160.2 - $179.79 $165,646 - $185,902
-1,034 Reduced 0.76%
134,934 $23.8 Million
Q3 2022

Nov 03, 2022

SELL
$161.33 - $179.52 $688,556 - $766,191
-4,268 Reduced 3.04%
135,968 $22.2 Million
Q2 2022

Aug 05, 2022

SELL
$168.19 - $186.01 $1.37 Million - $1.52 Million
-8,169 Reduced 5.5%
140,236 $24.9 Million
Q1 2022

May 02, 2022

SELL
$158.14 - $179.59 $385,229 - $437,481
-2,436 Reduced 1.61%
148,405 $26.3 Million
Q4 2021

Feb 09, 2022

SELL
$155.93 - $173.01 $182,126 - $202,075
-1,168 Reduced 0.77%
150,841 $25.8 Million
Q3 2021

Nov 09, 2021

SELL
$161.5 - $179.47 $480,785 - $534,282
-2,977 Reduced 1.92%
152,009 $24.5 Million
Q2 2021

Aug 06, 2021

SELL
$159.48 - $171.07 $872,355 - $935,752
-5,470 Reduced 3.41%
154,986 $25.5 Million
Q1 2021

May 10, 2021

SELL
$153.07 - $170.48 $848,926 - $945,482
-5,546 Reduced 3.34%
160,456 $26.4 Million
Q4 2020

Feb 10, 2021

SELL
$137.11 - $157.38 $1.32 Million - $1.52 Million
-9,646 Reduced 5.49%
166,002 $26.1 Million
Q3 2020

Nov 10, 2020

BUY
$140.38 - $153.83 $226,432 - $248,127
1,613 Added 0.93%
175,648 $26.2 Million
Q2 2020

Aug 19, 2020

SELL
$128.81 - $155.51 $150,836 - $182,102
-1,171 Reduced 0.67%
174,035 $24.5 Million
Q1 2020

May 08, 2020

SELL
$111.14 - $153.99 $325,417 - $450,882
-2,928 Reduced 1.64%
175,206 $23 Million
Q4 2019

Feb 10, 2020

BUY
$127.5 - $146.44 $240,720 - $276,478
1,888 Added 1.07%
178,134 $26 Million
Q3 2019

Nov 04, 2019

SELL
$126.95 - $142.14 $587,524 - $657,823
-4,628 Reduced 2.56%
176,246 $22.8 Million
Q2 2019

Aug 20, 2019

SELL
$131.15 - $144.24 $257,185 - $282,854
-1,961 Reduced 1.07%
180,874 $25.2 Million
Q1 2019

May 02, 2019

SELL
$125.72 - $139.79 $173,870 - $193,329
-1,383 Reduced 0.75%
182,835 $25.6 Million
Q4 2018

Feb 04, 2019

SELL
$122.84 - $147.84 $928,056 - $1.12 Million
-7,555 Reduced 3.94%
184,218 $23.8 Million
Q3 2018

Nov 06, 2018

SELL
$121.58 - $142.88 $147,111 - $172,884
-1,210 Reduced 0.63%
191,773 $26.5 Million
Q2 2018

Aug 03, 2018

SELL
$119.4 - $131.76 $299,574 - $330,585
-2,509 Reduced 1.28%
192,983 $23.4 Million
Q1 2018

May 10, 2018

SELL
$125.1 - $148.14 $501,651 - $594,041
-4,010 Reduced 2.01%
195,492 $25.1 Million
Q4 2017

Feb 06, 2018

SELL
$131.22 - $143.62 $563,589 - $616,847
-4,295 Reduced 2.11%
199,502 $27.9 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $26.4 Million - $27.6 Million
203,797
203,797 $26.5 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $410B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Gamble Jones Investment Counsel Portfolio

Follow Gamble Jones Investment Counsel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamble Jones Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Gamble Jones Investment Counsel with notifications on news.